Skip 
Navigation Link

1215 South Walnut Ave.
Demopolis, AL 36732 map map 

Access to Care: 1-800-239-2901

Medical Disorders
Resources
Basic InformationLookupsLatest News
Babies' Exposure to Household Cleaning Products Tied to Later Asthma RiskGrowing Up in U.S. 'Stroke Belt' Bad for the Brain Later in LifeStricter Clean Air Laws Could Save Thousands of Lives a Year: Study9/11 Study Shows PTSD Tied to Earlier DeathBedside 'Sitters' May Not Prevent Hospital FallsDoes Race Play a Part in ICU Outcomes?Coronavirus Doesn't Have to Scare You or Your Kids, Psychologists SayFlame Retardants, Pesticides Remain Threat to U.S. Health: StudyVirtual Reality Can Bring Real-Life PainAre Doctors Discarding 'Injured' Kidneys That Might Be Used for Transplant?AHA News: Worried About Dementia? Check This Blood Pressure NumberSleep Disturbances May Trigger MigraineVaccinations Rose After California Curbed ExemptionsGrowing Obesity Rates May Contribute to Climate ChangeHealth Tip: Do's and Don'ts While Waiting for an AmbulanceAHA News: Could Fish Oil Fight Inflammation?How to Prevent Holiday HeadachesU.S. Poison Centers Field More Calls About Psychoactive Substances: StudyInfants May Not Be as Immune to Measles as ThoughtHealth Tip: Do's and Don'ts for Calling 911Health Tip: A Well-Stocked First-Aid KitOpioids Won't Help Arthritis Patients Long-Term: StudyScreening Truckers for Sleep Apnea Cuts Health Insurance CostsDo You Take Biotin Supplements? They Could Affect Your Medical TestsFewer Opioids After Eye Surgery Don't Mean More Post-Op PainReport Finds Americans' Health Is FlaggingWildfire Smoke Threatens Health for Miles AroundIs Head Injury Causing Dementia? MRI Might ShowAHA News: How Does Hormone Therapy Affect Heart Health in Transgender People?Many Women Are Sharing Breast Milk, and That Has Health Experts WorriedLanguage Barriers May Mean Repeat Visits to the HospitalVision Problems Strike More Than 2 Billion GloballyWhat Are the Risks of Pain Relief Alternatives to Opioids?'Alarming' Number of Lupus Patients Use Opioids for Pain: StudyMental Ills May Put Veterans at Higher Odds for Heart TroubleU.S. Minorities' Recent Health Gains May Be SlowingDon't Let Fear of Cancer Keep You From Doctor VisitsOpioid Prescriptions for Eye Surgery Patients SurgeIntense Gaming Can Trigger Irregular Heartbeat, Fainting in Some PlayersCould Profit Be a Factor in Kidney Transplant Decisions?Treatment for Very-Preterm Infants May Lead to Antibiotic ResistanceHurricane Dorian Can Wreak Havoc on Heart HealthMore CT, MRI Scans Being Used, Despite Calls to Cut BackThousands of Kidneys Thrown Away by U.S. Transplant CentersRestless Legs Syndrome Might Raise Risk of Suicide, Self-HarmMixing Marijuana With Opioids May Not Be Good for Mental HealthAHA News: Hurricane Checklist: Batteries, Bottled Water – And A Plan for Heart CareFor Asthmatic Kids in Tough Neighborhoods, Family Is KeySmog Could Land Newborns in Intensive CareTraveling Abroad? Make Sure Your Measles Shot Is Up to Date
Questions and AnswersVideosLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

FDA Grants First Approvals for Generic Versions of Lyrica


HealthDay News
Updated: Jul 23rd 2019

new article illustration

TUESDAY, July 23, 2019 (HealthDay News) -- Nine drug companies have received approval for the first generic versions of Lyrica (pregabalin), the U.S. Food and Drug Administration announced.

The generic versions of Lyrica have been approved to manage neuropathic pain from diabetic peripheral neuropathy or spinal cord injury, postherpetic neuralgia, and fibromyalgia. The agency also approved the generic versions as adjunctive therapy for partial onset seizures in patients aged 17 years and older.

The FDA noted that pregabalin must be dispensed with a patient medication guide. Pregabalin carries the risks for angioedema, hypersensitivity reactions, dyspnea, and wheezing. If patients rapidly discontinue using the drug, they could experience increased seizure frequency or other adverse reactions. As with other antiepileptic drugs, pregabalin could increase the risk for suicidal thoughts or behavior. It could also cause peripheral edema, and providers should be cautious when prescribing pregabalin with thiazolidinedione antidiabetic agents. The most commonly reported side effects of pregabalin include dizziness, somnolence, dry mouth, swelling, blurred vision, weight gain, and difficulty concentrating or paying attention.

Approvals for the generic versions of Lyrica were granted to Alembic Pharmaceuticals, Alkem Laboratories, Amneal Pharmaceuticals, Dr. Reddy's Laboratories, InvaGen Pharmaceuticals, MSN Laboratories, Rising Pharmaceuticals, Sciegen Pharmaceuticals, and Teva Pharmaceuticals.

More Information